Academic Editor: Marcello Iriti
Background: Candida albicans is responsible for a wide range of medical ailments, from harmless cutaneous to life-threatening bloodstream infections. Growing cases of antifungal-drug resistance strains of C. albicans become a rationale to explore and develop novel anti-candida agents. In this paper, we assessed the anti-candida activity of the methanolic extracts of various tropical medicinal plants from Myrtaceae, Poaceae, and Zingiberaceae, commonly used in Indonesia to treat fungal infections. Methods: Candida albicans strain ATCC 10231 was used as a subject to assess the anti-Candida activities of plant methanolic extracts through disc diffusion assay. Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal Concentration (MFC) were observed. Results: All plant extracts in this study showed antifungal activities against C. albicans. Among them, Cymbopogon citratus, Curcuma xanthorrhiza, Curcuma aeruginosa, and Zingiber officinale var. rubrum showed the lowest MIC and MFC value of 3.8 mg/mL. Conclusions: The growth inhibition of C. albicans on disc diffusion assay was demonstrated by Z. officinale var. rubrum and C. longa, which were comparable to antifungal nystatin. Further investigation of the chemical constituents of the extracts and the cytotoxicity test is needed to further develop plant-derived anti-candida agents.
Candidiasis refers to infections caused by fungi of the genus Candida [1, 2]. These infections may be cutaneous, mucosal (oral, oesophageal, and vulvovaginal candidiasis), or invasive (bloodstream and deep-seated candidiasis) [3, 4, 5]. The clinical spectrum of candidiasis varies from mild mucocutaneous infections to life-threatening candidemia (bloodstream infections), brain abscess, and endocarditis (infection of heart’s inner lining) [6, 7]. Candidiasis is recognized as one of the most common infections, with the global burden for superficial cutaneous and mucosal candidiasis being over 1,000,000,000 and 130,000,000 annual cases, respectively [8, 9]. Furthermore, the estimated annual invasive candidiasis are 750,000 cases with a mortality rate of 40%–55%, especially in patients with risk factors such as immunodeficiency, advanced age, exposure to broad-spectrum antibiotics, cancer chemotherapy, organ transplantation, and prolonged stay in an intensive care setting [8, 10, 11].
Candida albicans, an opportunistic pathogen which is also a part of the
normal human microflora, is the most common causing agent of candidiasis [12, 13]. C. albicans is responsible for
One alternative of anti-candidal compounds is provided by plants. Some plant species produce secondary metabolites with anti-candidal activities, such as terpenes, terpenoids, and aromatic compounds [21]. A study reported that terpenes could inhibit cell growth, initiate apoptosis, and induce cell cycle arrest of yeast-like fungi, including C. albicans [22]. Terpenoids, a modified class of terpenes, can disrupt cell membrane integrity of C. albicans [23]. Meanwhile, eugenol, an aromatic compound, can kill C. albicans cell by disrupting its membrane morphology and function, causing oxidative stresses [24].
As a tropical country, Indonesia has a variety of medicinal plants which are traditionally used for treating C. albicans infection [25]. Plants from the Zingiberaceae family, such as Alpinia galanga, Curcuma longa, and Curcuma xanthorrhiza, were used for treating candidiasis [26, 27, 28]. Those plants produce anti-candidal secondary metabolites such as terpenoids (i.e., xanthorrhizol and curcumenol) and aromatic compounds (i.e., flavonoids and curcumin) [29, 30]. Another example is the fruit of clove Syzygium aromaticum L. (Myrtaceae), a native Indonesian plant whose main bioactive compound is anti-candidal eugenol [31].
Bioactive compounds from medicinal plants must be extracted first to be utilized as anti-candidal. The solvent is critical in the extraction process [32]. Methanol is an effective solvent for extracting anti-candidal compounds such as terpenoids, flavonoids, and polyphenol [33, 34]. Besides that, the maceration method can prevent the damage of samples’ bioactive components, especially the thermolabile ones [35]. This study aims to investigate the anti-candida (i.e., C. albicans strain ATCC 10231) activities of methanolic extracts of 11 medicinal plants from Indonesia. The result of this study is essential for developing anti-candidal food supplements and drugs.
This study used 11 plant species from three families, i.e., Myrtaceae, Poaceae, and Zingiberaceae (Table 1, Ref. [31, 36, 37, 38, 39, 40, 41, 42, 43, 44]). Plant materials were collected from Lawu Mountain, Jogorogo Village, Ngawi, East Java, Indonesia, at 7°3’31” S latitude and 112°32’0” E longitude (357 meters above sea level). Methanolic extract preparation was conducted based on a method developed by Wardana et al. [45]. One (1) kg of each plant powder was macerated with 3 L methanol for 24 hours at room temperature. The maceration process was repeated three times, after which the filtrate was passed through a Buchner funnel to obtain methanol extract. Each plant extract was then concentrated on a rotary vacuum evaporator to obtain a thick methanol extract. The thick methanol extract was then diluted in Dimethyl sulfoxide (DMSO) to obtain extract concentration of 500, 250, 125, 100, 50, and 25 mg/mL for anti-candida assay.
Family/species | Local name | Common name | Part used | Reported bioactive compounds | References |
Myrtaceae | |||||
Syzygium aromaticum | Cengkeh | Clove | Fruit | Eugenol, |
[31] |
Poaceae | |||||
Cymbopogon citratus | Serai/Sereh | Lemon grass | Bulb | Geraniol, geranial, geranyl acetate, myrcene, neral | [36] |
Zingiberaceae | |||||
Boesenbergia rotunda | Temu kunci | Fingerroot | Rhizome | Kaempferol, quercetin, hesperidin, caffeic acid, naringin, chlorogenic acid, p-coumaric acid, luteolin, diosmin | [37] |
Curcuma aeruginosa | Temu hitam | - | Rhizome | Camphor, germacrone, borneol, 1,8-cineole, curzerene, germacrene a, germacrene b, camphene, limonene | [38] |
Curcuma longa | Kunyit | Turmeric | Rhizome | Digalloyl-hexoside, caffeic acid hexoside, curdione, coumaric acid, caffeic acid, sinapic acid, qurecetin-3-d-galactoside, casuarinin, bisdemethoxycurcumin, curcuminol, demethoxycurcumin, isorhamnetin, valoneic acid bilactone, curcumin, curcumin-O-glucuronide | [39] |
Curcuma heyneana | Temu giring | - | Rhizome | Curcumanolide A, oxycurcumenol, curcumenone, labda-8(17),12-diene-15,16-dial, isocurcumenol, curcumenol, germacrone | [40] |
Curcuma xanthorrhiza | Temulawak | Javanese turmeric | Rhizome | Xanthorrhizol, |
[38] |
Curcuma zedoaria | Kunyit putih | White turmeric | Rhizome | Curcumin, ethyl paramethoxycinnamate, |
[41] |
Zingiber montanum | Bangle | - | Rhizome | cis-3-(3’,4’-dimethoxyphenyl)-4-[(E)-3”’,4”’-dimethoxystyryl]cyclohex1-ene, (E)-4-(3’,4’-dimethoxyphenyl) but-3-en-1-ol, 3,4-dimethoxybenzoic acid, 8-(13,14-dimethoxyphenyl)-2-methoxynaphto-1,4-quinone, and |
[42] |
Zingiber officinale var. rubrum | Jahe merah | Red ginger | Rhizome | 6-gingerol, 8- gingerol, 6-shogaol, 8-shogaol, quercetin, catechin, rutin, gallic acid, epicatechin, kaempferol, cinnamic acid, tannic acid, syringic acid, ferulic acid, geraniol, 1.8- cineole, linalool, farnesol | [43] |
Zingiber officinale Rosc | Jahe putih | White ginger | Rhizome | Eudesmol, |
[44] |
The anti-candida activity of the 11 plants’ methanolic extract was tested using a modified version of document M27-A3 published by the Clinical and Laboratory Standards Institute (CLSI) [46, 47, 48]. All assays were done in duplicate.
C. albicans ATCC 10231 used in this study was obtained from the
Microbiology Laboratory, Department of Biology, Universitas Airlangga, Indonesia.
One colony of C. albicans ATCC 10231 was inoculated in a Potato Dextrose
Broth (PDB) and grown overnight at 37 °C (150 rpm). 60
C. albicans culture from the previous step (100
Different concentrations of the methanolic extracts (1.85–250 mg/mL) were added
to PDB media inoculated with 105 CFU/mL C. albicans in a 96-well
microplate. The OD at 600 nm was measured using a microplate reader before and
after incubation at 37 °C for 48 hours. The minimum inhibitory concentration
(MIC) or the lowest concentration of the plant methanolic extract that prevents
C. albicans’ growth is observed when there is no increase in OD600 value
after 48 hours of incubation. Meanwhile, the minimum fungicidal concentration
(MFC) was determined by spreading 100
Methanol extraction of 1 kg dry powdered plant materials yielded concentrated extract ranging from 72.1 to 183.5 gr (Table 2). The highest yield of plant extract was obtained from C. longa, while C. citratus gave the lowest result.
Plant species | pH | % Yield |
Syzygium aromaticum | 5.7 | 15.77 |
Cymbopogon citratus | 5.5 | 7.21 |
Boesenbergia rotunda | 5.9 | 16.28 |
Curcuma aeruginosa | 6.2 | 15.03 |
C. longa | 6.1 | 18.35 |
C. heyneana | 6.1 | 15.15 |
C. xantorrhiza | 6.2 | 17.87 |
C. zedoaria | 6.0 | 13.52 |
Zingiber montanum | 5.8 | 10.06 |
Z. officinale var. rubrum | 5.9 | 10.80 |
Z. officinale Rosc | 5.9 | 9.42 |
Using a disc diffusion assay, 11 plant species commonly used in Indonesian traditional medicine were evaluated for their antifungal activity against C. albicans. The results revealed that all plant extracts could inhibit C. albicans growth (Table 3). Two species, i.e., Z. officinalevar. rubrum and C. longa showed a more extensive inhibition zone than nystatin at concentrations as low as 25 mg/mL (Table 3 and Fig. 1). The concentration of MIC and MBC from 11 plant species ranged from 3.91 to 15.62 mg/mL (Table 4). Methanolic extract of four species (i.e., C. citratus, C. aeruginosa, C. xanthorrhiza, and Z. officinale var. rubrum) had the lowest MIC and MBC value at 3.9 mg/mL (Table 4).
Plant species | Concentration (mg/mL) | Inhibition Zone (mm) |
Syzygium aromaticum | 25 | 7.25 |
50 | 7.60 | |
100 | 8.40 | |
125 | 8.18 | |
250 | 11.08 | |
500 | 11.10 | |
Cymbopogon citratus | 25 | 7.08 |
50 | 6.95 | |
100 | 6.95 | |
125 | 6.73 | |
250 | 7.03 | |
500 | 6.68 | |
Boesenbergia rotunda | 25 | 7.98 |
50 | 8.54 | |
100 | 7.95 | |
125 | 10.47 | |
250 | 11.73 | |
500 | 15.15 | |
Curcuma aeruginosa | 25 | 6.70 |
50 | 7.30 | |
100 | 7.53 | |
125 | 7.25 | |
250 | 7.58 | |
500 | 7.30 | |
C. longa | 25 | 14.30 |
50 | 14.63 | |
100 | 13.95 | |
125 | 14.68 | |
250 | 17.13 | |
500 | 19.60 | |
C. heyneana | 25 | 6.75 |
50 | 7.63 | |
100 | 7.03 | |
125 | 6.63 | |
250 | 7.53 | |
500 | 8.53 | |
C. xantorrhiza | 25 | 9.53 |
50 | 9.15 | |
100 | 8.33 | |
125 | 9.15 | |
250 | 10.00 | |
500 | 12.73 | |
C. zedoaria | 25 | 6.63 |
50 | 6.38 | |
100 | 6.73 | |
125 | 7.55 | |
250 | 6.80 | |
500 | 7.05 | |
Zingiber montanum | 25 | 6.15 |
50 | 6.34 | |
100 | 6.19 | |
125 | 6.10 | |
250 | 6.13 | |
500 | 6.83 | |
Z. officinale var. rubrum | 25 | 12.48 |
50 | 14.18 | |
100 | 13.68 | |
125 | 14.20 | |
250 | 16.60 | |
500 | 16.48 | |
Z. officinale Rosc | 25 | 6.47 |
50 | 6.73 | |
100 | 7.45 | |
125 | 7.40 | |
250 | 6.83 | |
500 | 6.63 | |
Nystatin | 100 unit/disc | 12.20 |
DMSO | - | 0 |
Growth inhibition of C. albicans by Z. officinale var rubrum and C. longa. The methanol plant extract concentration used were 25, 50, 100, 125, 250, and 500 mg/mL. DMSO and nystatin (100 Units/disc) were used as the negative and positive control, respectively.
Plant species | MIC (mg/mL) | MFC (mg/mL) |
Syzygium aromaticum | 7.81 | 7.81 |
Cymbopogon citratus | 3.91 | 3.91 |
Boesenbergia rotunda | 15.62 | 15.62 |
Curcuma aeruginosa | 3.91 | 3.91 |
Curcuma longa | 7.81 | 7.81 |
Curcuma heyneana | 7.81 | 7.81 |
Curcuma xantorrhiza | 3.91 | 3.91 |
Curcuma zedoaria | 15.62 | 15.62 |
Zingiber montanum | 7.81 | 7.81 |
Zingiber officinale var. rubrum | 3.91 | 3.91 |
Zingiber officinale Rosc | 7.81 | 7.81 |
In many Southeast Asian countries, medicinal plants are commonly used for antifungal activities. Among others, three plant species, i.e., S. aromaticum, C. citratus, C. xanthorrhiza, are widely used for treating candidiasis in Indonesia, Malaysia, and Thailand [26, 49, 50]. Extracting their organic solvent is one of the approaches to improve their anti-candida activities by bringing out related bioactive compounds [51, 52].
Clove fruit (S. aromaticum) methanolic extract contains anti-candidal compounds such as flavonoids, polyphenols, and terpenoids [53, 54]. However, there are limited reports on the antifungal activity of clove fruit methanolic extract. To date, only one study by Vizhi et al. [54] evaluated the antifungal activity of the undiluted methanolic extract against C. albicans via disc diffusion assay. The reported inhibition activity was weaker than the results of the current study, where a much lower concentration of clove fruit methanolic extract was used. Furthermore, to our knowledge, our results are the first to report the MIC and MFC of clove fruit methanolic extract against C. albicans. When compared to extracts from different solvents (methanolic, diethyl ether, ethyl acetate, and n-hexane) of other parts of the plant (e.g., buds), our results are still superior in terms of growth inhibition observed in disc diffusion assay [55].
Methanolic extract of C. citratus bulb contained anti-candidal
monoterpenes such as citral and geraniol. Citral can block the cell membrane
synthesis and inhibit the cellular respiration of C. albicans [56].
Meanwhile, geraniol disrupts C. albicans membrane integrity and function
by inhibiting ergosterol biosynthesis and plasma membrane H
Two other species, i.e., C. longa and Z. officinale Rosc, are extensively explored for their anti-candidal activities. The main anti-candidal compound of these plants are polyphenol curcumin and gingerol, respectively, which damage C. albicans cell wall and plasma membrane [61, 62]. Previous studies [63, 64] reported a higher MIC and MFC of C. longa methanolic extract than ours. Meanwhile, MIC and MFC of Z. officinale Rosc from our study are higher than previously reported results [65, 66].
Up to our knowledge, there have not been any previous reports on MIC and MFC values of B. rotunda, C. heyneana, C. zedoaria, and Z. montanum methanolic extract. However, previous studies using the ethanolic extract from B. rotunda and C. zedoaria showed lower MIC and MFC values from the ethanolic extract of B. rotunda (MIC: 2.5 mg/mL, MFC: 5 mg/mL) and C. zedoaria (MIC90: 7.8 mg/mL) as compared to our results [67, 68, 69, 70]. On the other hand, a previous study usingan essential oil extracted from hydrodistillation of Z. montanum also showed higher MIC and MFC values than our results [71]. Meanwhile, the only study in anti-candidal activity of C. heyneana [72] reported an inhibition zone in disc diffusion assay comparable to our result.
Among all methanolic extracts from Zingiberaceae plants used in this study, three samples (i.e., C. aeruginosa, C. xantorrhiza, and Zingiber officinale var. rubrum) showed the lowest MIC and MBC. The rhizomes of C. aeruginosa and C. xantorrhiza mainly contain anti-candidal monoterpene compounds camphor and terpinolene, respectively [38]. Camphor can downregulate genes related to biofilm formation, thus reducing the virulence of C. albicans [73]. Terpinolene works by disrupting C. albicans membrane integrity [74]. Another bioactive compound from C. xantorrhiza is xanthorhizzol, a bisabolane-type sesquiterpenoid that can disrupt C. albicans cell membrane [75]. Meanwhile, the main bioactive compounds of Z. officinale var. rubrum with antifungal activity are geraniol, 1.8-cineole, linalool, and farnesol which modify the permeability of C. albicans cell wall and sesquiterpenes ar-curcumene, which disrupts the cell membrane structure [27, 76].
Philip et al. [77] showed no inhibition zone in the disc diffusion assay of C. aeruginosa methanolic extract, even at a high concentration of 500 mg/mL. Another study by Rukayadi et al. [78] showed a higher MIC and MFC values of methanolic extract of C. aeruginosa, which is around 7 times and 13 times than our study, respectively. In the case of C. xantorrhiza, Novianti et al. [79] showed a higher inhibition zone (12.5 mm) than our result using 20 mg/mL methanolic extract. No studies reported MIC and MFC of methanolic C. xantorrhiza. However, two studies [80, 81] reported a higher MIC and MFC of C. xantorrhiza from ethanolic extract than ours. For a similar reason, only one study [82] that used an ethanolic extract of Z. officinale var. rubrum showed a comparable MIC and MFC to our results.
Even though the MIC values from all 11 methanolic plant extracts are sometimes lower than in similar studies, they still showed antifungal activity against Candida albicans. The MIC values of this study can be considered in the moderate to low range of anti-candida activity compared to other similar studies [83, 84, 85, 86]. The differences in anti-candida activity from previous studies might be influenced by several factors, such as the soil and climate where the plant materials were sampled [87, 88, 89]. Further investigation of the chemical constituents of the extracts and the cytotoxicity test against mammalian cells and test animals are needed to further develop plant extracts as the components of anti-candida drugs and health supplements.
Our results confirm the antifungal activities of methanolic extracts of 11 tropical medicinal plants from Indonesia against Candida albicans ATCC 10231. Among them, the methanolic extracts of C. citratus, C. xanthorrhiza, C. aeruginosa, and Z. officinale var. rubrum had the lowest MIC and MFC value, whereas in relatively low concentration, Z. officinale var. rubrum and C. longa showed antifungal activity comparable to nystatin. This study provides the first report on MIC and MFC values of S. aromaticum fruit, C. xantorrhiza, and Z. officinale var. rubrum methanolic extract. However, these results need to be interpreted cautiously, as this study only tested one strain of C. albicans. Different C. albicans strains can give different results due to their difference in sensitivity toward anti-candida plant extract. Therefore, further study using other C. albicans strains, including the ones obtained from patients (clinical strain), will be necessary to offer a bigger picture of anti-candida activity of plant extracts on C. albicans.
AG and YSWM conceptualized the research study. AG and APW designed the research methodology. AG, APW, AYS, MRAW, NHW, VRH and NIDD performed the research and analyzed the data. AG, APW, AYS, MRAW, NHW, VRH and NIDD wrote the manuscript. AG, YSWM and ANK reviewed and contributed to editorial changes in the manuscript. AG, YSWM, NSA and ANK supervised the research. YSWM acquired the funding for the research. All authors read and approved the final manuscript.
Not applicable.
Not applicable.
This research was funded by Universitas Airlangga via the “Hibah Penelitian Riset Grup”, with research grant No. 343/UN3.14/PT/2020.
The authors declare no conflict of interest.
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.